🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this phase 2 study is to assess the feasibility and efficacy...
Status
Terminated
Location
Duke University Medical Center
Start Date
2020-11-04
Trial ID
NCT04434560
Treatments Being Tested
Subjects with resectable melanoma will receive neoadjuvant nivolumab follow...
Status
Active Not Recruiting
Location
Duke Cancer Institute
Start Date
2020-01-01
Trial ID
NCT04013854
Treatments Being Tested
The main goal of this research study is to determine how nivolumab and nivo...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2020-09-02
Trial ID
NCT04401995
Treatments Being Tested
DONIMI is a phase 1b trial testing the combination of domatinostat + nivolu...
Status
Completed
Location
Melanoma Institute Australia
Start Date
2020-01-07
Trial ID
NCT04133948
Treatments Being Tested
The purpose of this study is to determine safety profile, initial response ...
Status
Completed
Location
Duke University Medical Center
Start Date
2014-05
Trial ID
NCT02115243
Treatments Being Tested
Rationale: The randomized trial NADINA has demonstrated that neoadjuvant tr...
Status
Recruiting
Location
Erasmus MC
Start Date
2025-04-23
Trial ID
NCT06754904
Treatments Being Tested
The purpose of this study is to see the effect of adding a systemic study d...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2011-02
Trial ID
NCT01323517
Treatments Being Tested
The NeAT Glio trial will evaluate whether the addition of ipilimumab prior ...
Status
Terminated
Location
Aberdeen Royal Infirmary
Start Date
2022-08-24
Trial ID
NCT05074992
Treatments Being Tested
This randomized phase II trial is studying how well giving ipilimumab with ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2010-12-28
Trial ID
NCT01134614
Treatments Being Tested
Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma...
Status
Completed
Location
James P. Wilmot Cancer Center at University of Rochester Medical Center
Start Date
2018-07-17
Trial ID
NCT03463408
Treatments Being Tested